Evidence map›Paper›PMID 41454095›Full record

ArticleJournal of cancer survivorship : research and practice2025

Barriers and facilitators to prostate cancer healthcare in Black men in the UK: from diagnosis to survivorship.

Dena Ettehad, Hafsa Mohammed, Julia V Bailey, Donald Schloss, Kate Walters, Samuel W D Merriel, William Kinnaird, Greg Shaw, Mike Kirby, Dipesh P Gopal and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dena EttehadPrimary Care and Population Health Department, Institute of Epidemiology and Health Care, University College London, London, UK.
Hafsa MohammedPrimary Care and Population Health Department, Institute of Epidemiology and Health Care, University College London, London, UK.
Julia V BaileyPrimary Care and Population Health Department, Institute of Epidemiology and Health Care, University College London, London, UK.
Donald SchlossBlack Prostate Cancer Network, London, UK.
Kate WaltersPrimary Care and Population Health Department, Institute of Epidemiology and Health Care, University College London, London, UK.
Samuel W D MerrielCentre for Primary Care & Health Services Research, University of Manchester, Manchester, UK.
William KinnairdUniversity College London Hospital, London, UK.
Greg ShawUniversity College London Hospital, London, UK.
Mike KirbyBritish Society for Sexual Medicine, Staffordshire, UK.
Dipesh P GopalCentre for Primary Care, Wolfson Institute of Population Health Science, Queen Mary University of London, London, UK.
Qizhi HuangPopulation Health, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.
Hilary BakerUniversity College London Hospital, London, UK.
Ruth PlackettPrimary Care and Population Health Department, Institute of Epidemiology and Health Care, University College London, London, UK.
Patricia SchartauPrimary Care and Population Health Department, Institute of Epidemiology and Health Care, University College London, London, UK. patricia.schartau@ucl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeProstate cancer (PCa) is the most common cancer among UK men, with Black men twice as likely to develop it and 2.5 times more likely to die from it than White men. This study identifies the barriers and facilitators to PCa healthcare in UK Black men and suggests ways to improve engagement and experiences across the care pathway.

methodsWe conducted semi-structured interviews with: (i) 12 UK Black men living with and beyond PCa. (ii) 15 UK Black men aged 45 or above. (iii) 15 UK multi-disciplinary healthcare professionals (HCPs). Interview transcripts were coded and analysed thematically, using the socioecological model to map barriers and facilitators.

resultsBarriers include mistrust of Western medicine, experiences of racism, fear and stigma around PCa, inadequate culturally sensitive information, underrepresentation of Black HCPs and Black men in healthcare spaces, limited culturally sensitive psychological support, and masculinity constructs affecting open discussions and preferences for minimally invasive treatments. Facilitators include racially concordant HCPs, culturally sensitive care, continuity of care and support from partners, peers, and local community groups.

conclusionOur findings underscore the need for tailored culturally sensitive information, community partnerships, and Black representation in both healthcare spaces and public health campaigns to improve healthcare engagement, foster trust and improve prostate cancer outcomes for Black men. IMPLICATIONS FOR CANCER SURVIVORS: Tailored healthcare for Black prostate cancer survivors is crucial. Providing culturally sensitive information, support from racially concordant HCPs and community support can significantly enhance survivorship experiences, engagement and potentially outcomes for Black men.

Indexed as

BarriersBlack menDiagnosisHealthcare engagementHealthcare experienceHealth inequalitiesNational health serviceProstate cancerQualitativeSurvivorshipTreatment

Identifiers

PMID41454095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.